Hutchison China MediTech names board member
Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet
Insight Weekly: Stocks limp into 2023; GCC banks set for rebound; deep-sea mining faces pushback
Infographic: The Big Picture 2023 Sustainability Outlook
The Big Picture for 2023: Assessing Investment Trends and the Impact of Investor Activism
Hutchison China MediTech Ltd. appointed Mok Shu Kam Tony to serve as an independent nonexecutive director.
Mok co-founded Hong Kong's Lung Cancer Research Group and is also a board member at Sanomics Ltd.
